SCPH Insider Trading - scPharmaceuticals Inc.

Shares Outstanding	53,678,797 shares
Insider Shares	13,362,926 shares
Insider Ownership	24.89 %
Total Insiders	37

Insider Sentiment Score

The Insider Sentiment Score finds the companies being bought by corporate insiders.

It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider accumulation.

See Highest Ranking Stocks

Officer Sentiment Score

The Officer Sentiment Score finds companies being bought by Corporate Officers.

By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.

Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider sentiment.

See Highest Ranking Stocks

Key Insider Metrics

This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.

For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).

Net Number of Insiders Buying (Rank)

0 ( )

5450 out of 11323

Net Number of Insiders Buying is the total number of insiders buying minus the total number of insiders selling in the last 90 days. The percentile rank is shown here (range from 0 to 100%).

Percent of Float Bought by Insiders (Rank)

0.000 %( )

5412 out of 11244

Percent of Float Bought by Insiders is the total number of shares purchased by insiders minus the total number of shares sold by insiders in the last 90 days, divided by the total float and multiplied by 100.

Insider Trading Chart

scPharmaceuticals Inc. insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

Insider Roster and Profitability Metrics

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.

See our leaderboard of most profitable insider traders.

Insider	Shares Owned	Split Adjusted
5AM Co-Investors IV, L.P. 10% Owner - [10%]	130,135	410,268
5AM Opportunities I (GP), LLC 10% Owner - [10%]	1,156,068	410,268
5AM Opportunities I, L.P. -	1,156,068	410,268
5AM Partners IV, LLC 10% Owner - [10%]	410,268	410,268
5AM Ventures IV, L.P. 10% Owner - [10%]	130,135	410,268
Mette Kirstine Agger Director, 10% Owner - [D] [10%]	3,183,986	3,183,986
Minnie Baylor-Henry	6,124
Sara Bonstein	12,248
Abraham Ceesay	80,971
Dorothy Coleman Director - [D]	14,348	14,348
John D Diekman 10% Owner - [10%]	130,135	410,268
Mason Freeman	6,124

Insider	Shares Owned	Split Adjusted
Abhay Gandhi	0
Hudson Frederick M.	6,124
Samuel D Isaly 10% Owner - [10%]	3,409,865	3,409,865
Ignelzi Troy A.	42,616
Khattar Jack A. Director - [D]	5,000	5,000
Peter Kolchinsky 10% Owner - [10%]	2,727,446	2,727,446
Lundbeckfond Invest A/S 10% Owner - [10%]	3,183,986	3,183,986
Rachael Nokes CFO and Treasurer - [O]	156,061	156,061
Orbimed Advisors Llc 10% Owner - [10%]	252,858	252,858
OrbiMed Capital GP VI LLC 10% Owner - [10%]	231,200	252,858
OrbiMed Genesis GP LLC 10% Owner - [10%]	231,200	252,858
Kush Parmar	6,124

Insider	Shares Owned	Split Adjusted
Ra Capital Management, Llc 10% Owner - [10%]	2,727,446	2,727,446
RA Capital Healthcare Fund LP 10% Owner - [10%]	2,727,446	2,727,446
Scott M Rocklage 10% Owner - [10%]	130,135	410,268
Leonard D Schaeffer Director - [D]	54,451	54,451
Dilip S Shanghvi 10% Owner - [10%]	357,143	357,143
Jonathan Silverstein Director - [D]	2,576,532	2,576,532
Pharmaceutical Industries Ltd Sun 10% Owner - [10%]	357,143	357,143
Schwab Andrew J. 10% Owner - [10%]	537,301	410,268
Shah Rajeev M. 10% Owner - [10%]	2,727,446	2,727,446
Sun Pharma (Netherlands) B.V. 10% Owner - [10%]	357,143	357,143
Sun Pharmaceutical Industries, Inc. 10% Owner - [10%]	357,143	357,143
John H Tucker President and CEO, Director - [D] [O]	440,847	440,847
Klaus R Dr Veitinger	6,124

Report errors via our new Insider Auditing Tool

Track Records of Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SCPH / scPharmaceuticals Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2024-08-13	ORBIMED ADVISORS LLC	478,342	4.0000	478,342	4.0000	1,913,368	345	5.8400	880,149	46.00
2024-08-13	ORBIMED ADVISORS LLC	21,658	4.0000	21,658	4.0000	86,632
2022-11-25	ORBIMED ADVISORS LLC	762,380	5.2500	762,380	5.2500	4,002,495
2021-12-03	Khattar Jack A.	5,000	3.9138	5,000	3.9138	19,569
2021-12-03	Tucker John H	10,000	3.9553	10,000	3.9553	39,553
2020-05-26	Schwab Andrew J.	578,034	8.6500	578,034	8.6500	4,999,994
2020-05-21	ORBIMED ADVISORS LLC	231,200	8.6500	231,200	8.6500	1,999,880
2020-05-21	ORBIMED ADVISORS LLC	1,156,083	8.6500	1,156,083	8.6500	10,000,118
2020-02-14	RA CAPITAL MANAGEMENT, LLC	271,993	8.2000	271,993	8.2000	2,230,343

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SCPH / scPharmaceuticals Inc. Insider Trades

Track Records of Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SCPH / scPharmaceuticals Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2022-10-10	5AM Partners IV, LLC	87,036	4.0900	87,036	4.0900	355,977	0	4.0200	-6,092	-1.71
2022-10-10	5AM Partners IV, LLC	19,017	4.0900	19,017	4.0900	77,780
2022-10-10	5AM Partners IV, LLC	456,413	4.0900	456,413	4.0900	1,866,729
2022-10-06	5AM Partners IV, LLC	5,808	5.0200	5,808	5.0200	29,156
2022-10-06	5AM Partners IV, LLC	1,269	5.0200	1,269	5.0200	6,370
2022-10-06	5AM Partners IV, LLC	30,457	5.0200	30,457	5.0200	152,894
2022-09-07	5AM Partners IV, LLC	6,793	4.7500	6,793	4.7500	32,267
2022-09-07	5AM Partners IV, LLC	30,173	4.7500	30,173	4.7500	143,322
2022-09-07	5AM Partners IV, LLC	163,034	4.7500	163,034	4.7500	774,412

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

File Date	Trade Date	Form	Insider	Ticker	Security Title	Code	Direct	Exercise Price	Unit Price	Units Changed	Value Changed (1K)	Remaining Options	Remaining Shares
2025-02-12	2025-02-11	4	Tucker John H	SCPH	Common Stock	A - Award	D			-200,000			440,847
2025-02-12	2025-02-11	4	Nokes Rachael	SCPH	Common Stock	A - Award	D			88,445			156,061
2025-01-07	2025-01-03	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		3.5587	-5,235	-19		67,616
2025-01-07	2025-01-03	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		3.5587	-13,360	-48		240,847
2024-08-28	2024-08-06	4/A	Nokes Rachael	SCPH	Common Stock	M - Exercise	D		1.6600	10,445	17		72,851
2024-08-28	2024-08-26	4	SCHAEFFER LEONARD D	SCPH	Common Stock	M - Exercise	D		3.3700	6,124	21		54,451
2024-08-28	2024-08-26	4	SCHAEFFER LEONARD D	SCPH	Common Stock	M - Exercise	D		1.6600	5,223	9		48,327
2024-08-15	2024-08-13	4	ORBIMED ADVISORS LLC See footnotes	SCPH	Common Stock	P - Purchase	I		4.0000	21,658	87		252,858
2024-08-15	2024-08-13	4	ORBIMED ADVISORS LLC See footnotes	SCPH	Common Stock	P - Purchase	I		4.0000	478,342	1,913		5,806,670
2024-08-08	2024-08-06	4	Nokes Rachael	SCPH	Common Stock	M - Exercise	D			10,445			72,851
2024-01-22	2024-01-18	4	Nokes Rachael	SCPH	Common Stock	A - Award	D			41,840			62,406
2024-01-22	2024-01-18	4	Tucker John H	SCPH	Common Stock	A - Award	D			113,560			254,207
2024-01-03	2024-01-02	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		6.3900	-1,027	-7		20,566
2024-01-03	2024-01-02	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		6.3900	-4,942	-32		140,647
2023-01-23	2023-01-19	4	Nokes Rachael	SCPH	Common Stock	A - Award	D		6.1400	11,700	72		21,593
2023-01-23	2021-02-25	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		7.2700	-1,976	-14		9,893
2023-01-23	2020-02-25	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		10.0900	-1,981	-20		11,869
2023-01-23	2023-01-19	4	Tucker John H	SCPH	Common Stock	A - Award	D		6.1400	66,665	409		145,589
2022-11-29	2022-11-25	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		5.2500	762,380	4,002		5,328,328
2022-10-11	2022-10-10	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		4.0900	-87,036	-356		410,268
2022-10-11	2022-10-10	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		4.0900	-19,017	-78		92,983
2022-10-11	2022-10-10	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		4.0900	-456,413	-1,867		2,231,601
2022-10-11	2022-10-06	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		5.0200	-5,808	-29		497,304
2022-10-11	2022-10-06	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		5.0200	-1,269	-6		112,000
2022-10-11	2022-10-06	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		5.0200	-30,457	-153		2,688,014
2022-10-11	2022-10-07	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		4.9800	-10,288	-51		78,924
2022-10-11	2022-10-07	4	Tucker John H	SCPH	Common Stock	M - Exercise	D			42,250			89,212
2022-09-08	2022-09-07	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		4.7500	-30,173	-143		503,112
2022-09-08	2022-09-07	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		4.7500	-6,793	-32		113,269
2022-09-08	2022-09-07	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		4.7500	-163,034	-774		2,718,471
2022-09-08	2022-09-06	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		5.5200	-4,016	-22		533,285
2022-09-08	2022-09-06	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		5.5200	-904	-5		120,062
2022-09-08	2022-09-06	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		5.5200	-21,702	-120		2,881,505
2022-04-13	2022-04-11	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		5.0000	-40,733	-204		537,301
2022-04-13	2022-04-11	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		5.0000	-9,171	-46		120,966
2022-04-13	2022-04-11	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		5.0000	-220,096	-1,100		2,903,207
2022-02-01	2022-01-31	4	Nokes Rachael	SCPH	Stock Option (Right to Buy)	A - Award	D	4.31		54,700		54,700
2022-02-01	2022-01-31	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	4.31		249,000		249,000
2021-12-06	2021-12-03	4	Khattar Jack A.	SCPH	Common Stock	P - Purchase	D		3.9138	5,000	20		5,000
2021-12-06	2021-12-03	4	Tucker John H	SCPH	Common Stock	P - Purchase	D		3.9553	10,000	40		46,962
2021-06-10	2021-06-08	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	5.70		16,300		16,300
2021-06-10	2021-06-08	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	5.70		16,300		16,300
2021-06-10	2021-06-08	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	5.70		16,300		16,300
2021-06-10	2021-06-08	4	Abraham William Tober	SCPH	Stock Option (Right to Buy)	A - Award	D	5.70		16,300		16,300
2021-06-10	2021-06-08	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	5.70		16,300		16,300
2021-06-10	2021-06-08	4	Bonstein Sara	SCPH	Stock Option (Right to Buy)	A - Award	D	5.70		16,300		16,300
2021-06-10	2021-06-08	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	5.70		16,300		16,300
2021-03-16	2021-03-15	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	S - Sale	I		7.0332	-110,588	-778		2,727,446
2021-03-16	2021-03-12	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	S - Sale	I		7.2162	-39,469	-285		2,838,034
2021-02-17	2021-02-16	4	Abraham William Tober	SCPH	Stock Option (right to buy)	A - Award	D	7.25		32,600		32,600
2021-01-27	2021-01-25	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	7.06		112,050		112,050
2021-01-27	2021-01-25	4	Nokes Rachael	SCPH	Stock Option (Right to Buy)	A - Award	D	7.06		49,200		49,200
2020-07-13	2020-07-08	4	Bonstein Sara	SCPH	Stock Option (right to buy)	A - Award	D	8.23		12,248		12,248
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Stock Option (right to buy)	A - Award	D	3.25		42,250		42,250
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Restricted Stock Units	M - Exercise	D			-42,250		0
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		7.3600	-10,288	-76		36,962
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Common Stock	M - Exercise	D			42,250			47,250
2020-06-11	2020-06-09	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-06-11	2020-06-09	4	Freeman Mason	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-06-11	2020-06-09	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-06-11	2020-06-09	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-06-11	2020-06-09	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-06-11	2020-06-09	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-06-11	2020-06-09	4	Agger Mette Kirstine	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-06-11	2020-06-09	4	Coleman Dorothy	SCPH	Stock Option (Right to Buy)	A - Award	D	7.96		6,124		6,124
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1,156,068
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1,156,068
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1,156,068
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1,156,068
2020-05-28	2020-05-26	4	Schwab Andrew J. By 5AM Opportunities I, L.P.	SCPH	Common Stock	P - Purchase	I		8.6500	578,034	5,000		578,034
2020-05-26	2020-05-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		8.6500	231,200	2,000		231,200
2020-05-26	2020-05-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		8.6500	1,156,083	10,000		4,565,948
2020-02-21	2020-02-14	4/A	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	P - Purchase	I		8.2000	271,993	2,230		3,518,998
2020-02-19	2020-02-14	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	P - Purchase	I		8.2000	271,993	2,230		3,247,005
2020-01-14	2020-01-10	4	Nokes Rachael	SCPH	Stock Option (Right to Buy)	A - Award	D	5.81		44,500		44,500
2020-01-14	2020-01-10	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	5.81		127,500		127,500
2019-12-17	2019-12-13	4	Tucker John H	SCPH	Common Stock	P - Purchase	D		5.2377	5,000	26		5,000
2019-06-20	2019-06-18	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-06-20	2019-06-18	4	Coleman Dorothy	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-06-20	2019-06-18	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-06-20	2019-06-18	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-06-20	2019-06-18	4	Freeman Mason	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-06-20	2019-06-18	4	Agger Mette Kirstine	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-06-20	2019-06-18	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-06-20	2019-06-18	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	3.37		6,124		6,124
2019-04-15	2019-04-11	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	P - Purchase	I		2.7000	389,862	1,053		3,247,005
2019-03-06		3	Nokes Rachael	SCPH	Common Stock		D						27,700
2019-03-06		3	Nokes Rachael	SCPH	Common Stock		D						27,700
2019-03-06		3	Nokes Rachael	SCPH	Common Stock		D						27,700
2018-07-24	2018-07-20	4	Freeman Mason	SCPH	Stock Option (Right to Buy)	A - Award	D	4.80		12,248		12,248
2018-07-24	2018-07-20	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	4.80		12,248		12,248
2018-06-21	2018-06-19	4	Coleman Dorothy	SCPH	Stock Option (Right to Buy)	A - Award	D	5.53		6,124		6,124
2018-06-21	2018-06-19	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	5.53		6,124		6,124
2018-06-21	2018-06-19	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	5.53		6,124		6,124
2018-06-21	2018-06-19	4	PARMAR KUSH	SCPH	Stock Option (Right to Buy)	A - Award	D	5.53		6,124		6,124
2018-06-21	2018-06-19	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	5.53		6,124		6,124
2018-06-21	2018-06-19	4	Agger Mette Kirstine	SCPH	Stock Option (Right to Buy)	A - Award	D	5.53		6,124		6,124
2018-06-21	2018-06-19	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	5.53		12,248		12,248
2018-02-13	2017-11-21	4/A	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Common Stock	P - Purchase	I		14.0000	654,762	9,167		3,183,986
2018-01-19	2018-01-17	4	Ceesay Abraham	SCPH	Stock Option (Right to Buy)	A - Award	D	12.23		80,971		80,971
2018-01-19	2018-01-17	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	12.23		100,000		100,000
2018-01-19	2018-01-17	4	Ignelzi Troy A.	SCPH	Stock Option (Right to Buy)	A - Award	D	12.23		42,616		42,616
2017-12-20	2017-12-19	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	M - Exercise	D	1.66		-22,631		5,223
2017-12-20	2017-12-19	4	SCHAEFFER LEONARD D	SCPH	Common Stock	M - Exercise	D		1.6600	22,631	38		57,449
2017-11-24	2017-11-21	4	SUN PHARMACEUTICAL INDUSTRIES LTD By Sun Pharmaceutical Industries, Inc.	SCPH	Series B Preferred Stock	C - Conversion	I			-13,000,000		0
2017-11-24	2017-11-21	4	SUN PHARMACEUTICAL INDUSTRIES LTD By Sun Pharma (Netherlands) B.V.	SCPH	Common Stock	P - Purchase	I		14.0000	357,143	5,000		357,143
2017-11-24	2017-11-21	4	SUN PHARMACEUTICAL INDUSTRIES LTD By Sun Pharmaceutical Industries, Inc.	SCPH	Common Stock	C - Conversion	I			1,810,536			1,810,536
2017-11-21		3	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock		I						5,714,286
2017-11-21		3	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock		I						5,714,286
2017-11-21		3	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock		I						5,714,286
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D By: Schaeffer Holdings LLC	SCPH	Series A Preferred Stock	C - Conversion	I			-309,501		0
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D	SCPH	Series A Preferred Stock	C - Conversion	D			-250,000		0
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D By: Schaeffer Holdings LLC	SCPH	Common Stock	C - Conversion	I			43,104			43,104
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D	SCPH	Common Stock	C - Conversion	D			34,818			34,818
2017-11-21	2017-11-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Series B Preferred Stock	C - Conversion	I			-18,500,000		0
2017-11-21	2017-11-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		14.0000	833,333	11,667		3,409,865
2017-11-21	2017-11-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	C - Conversion	I			2,576,532			2,576,532
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Series B Preferred Stock	C - Conversion	I			-302,652		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Series A Preferred Stock	C - Conversion	I			-443,708		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Series B Preferred Stock	C - Conversion	I			-7,263,649		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Series A Preferred Stock	C - Conversion	I			-10,649,003		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Common Stock	P - Purchase	I		14.0000	26,190	367		130,135
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Common Stock	C - Conversion	I			42,150			103,945
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Common Stock	C - Conversion	I			61,795			61,795
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Common Stock	P - Purchase	I		14.0000	628,572	8,800		3,123,302
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Common Stock	C - Conversion	I			1,011,623			2,494,730
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Common Stock	C - Conversion	I			1,483,107			1,483,107
2017-11-21	2017-11-21	4	SILVERSTEIN JONATHAN By: OrbiMed Private Investments VI, L.P.	SCPH	Series B Preferred Stock	C - Conversion	I			-18,500,000		0
2017-11-21	2017-11-21	4	SILVERSTEIN JONATHAN By: OrbiMed Private Investments VI, L.P.	SCPH	Common Stock	C - Conversion	I			2,576,532			2,576,532
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Series B Preferred Stock	C - Conversion	I			-7,067,945		0
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Series A Preferred Stock	C - Conversion	I			-11,092,383		0
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	I			984,366			2,529,224
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	I			1,544,858			1,544,858
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Series B Preferred Stock	C - Conversion	D			-7,067,945		0
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Series A Preferred Stock	C - Conversion	D			-11,092,383		0
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Common Stock	P - Purchase	D		14.0000	654,762	9,167		3,183,986
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	D			984,366			2,529,224
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	D			1,544,858			1,544,858
2017-11-21	2017-11-21	4	Coleman Dorothy	SCPH	Series A Preferred Stock	C - Conversion	D			-103,024		0
2017-11-21	2017-11-21	4	Coleman Dorothy	SCPH	Common Stock	C - Conversion	D			14,348			14,348

Open market or private purchase of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

Grant, award, or other acquisition of securities from the company (such as an option)

Conversion of derivative

Sale or transfer of securities back to the company

Payment of exercise price or tax liability using portion of securities received from the company

Gift of securities by or to the insider

Equity swaps and similar hedging transactions

Exercise or conversion of derivative security received from the company (such as an option)

A transaction voluntarily reported on Form 4

Other (accompanied by a footnote describing the transaction)

SCPH / scPharmaceuticals Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5